Sonuç Sayfası 2 için Endüstri: İlaç Üreticileri-Genel Borsası - Teklifler ve Fiyatlar
Fiyatlar, Piyasa Değerleri, PE ve EPS oranları ile tüm Hisse ve Net Varlıkların Listesi
Tüm ülkeler
- {{country.name}}
- Tüm ülkeler
- Amerika Birleşik Devletleri (50)
- Arjantin (13)
- Avustralya (1)
- Avusturya (13)
- Brezilya (14)
- Kanada (2)
- Şili (4)
- Çin (22)
- Finlandiya (2)
- Fransa (3)
- Almanya (58)
- Hong Kong (4)
- Macaristan (1)
- Hindistan (20)
- Endonezya (1)
- İtalya (5)
- Japonya (9)
- Meksika (14)
- Singapur (1)
- Güney Kore (3)
- ispanya (1)
- İsveç (3)
- İsviçre (6)
- Tayvan (1)
- Türkiye (1)
- Birleşik Krallık (20)
Tüm borsalar
- {{item.name}}
- Tüm borsalar
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (4)
- IOB (17)
- Istanbul (1)
- Jakarta (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (9)
- OTC Markets OTCPK (30)
- OTC Markets OTCQX (3)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (11)
- Shenzhen (11)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
Tüm sektörler
- {{item.name}}
- Tüm sektörler
- Sağlık Hizmetleri (279)
İlaç Üreticileri-Genel (279)
- {{item.name}}
- Tüm Sektörler
- Tarımsal Girdiler (323)
- Yapı Malzemeleri (471)
- Kimyasallar (605)
- Özel Kimyasallar (1353)
- Kereste ve Odun Üretimi (160)
- Kağıt ve Kağıt Ürünleri (269)
- Alüminyum (141)
- Bakır (216)
- Diğer Endüstriyel Metaller ve Madencilik (2765)
- Altın (1700)
- Gümüş (84)
- Diğer Değerli Metaller ve Madencilik (660)
- Kok Kömürü (71)
- Çelik (744)
- Otomobil ve Kamyon Bayileri (212)
- Otomobil Üreticileri (388)
- Otomobil Parçaları (1166)
- Rekreasyonel Taşıtlar (85)
- Döşemeler, Fikstürler ve Ev Eşyaları (507)
- Konut İnşaatı (214)
- Tekstil Üretimi (520)
- Giysi Üretimi (444)
- Ayakkabı ve Aksesuar (208)
- Ambalajlama ve Konteynerler (481)
- Kişisel Hizmetler (140)
- Restoranlar (539)
- Perakende Giyim (289)
- Büyük Mağazalar (276)
- Perakende Ev İyileştirme (106)
- Lüks Mallar (260)
- İnternet Üzerinden Perakende (408)
- Özel Perakende (547)
- Şans Oyunları (205)
- Dinlence (411)
- Konaklama (321)
- Tatil Yerleri ve Casino'lar (188)
- Seyahat Hizmetleri (192)
- Varlık Yönetimi (1966)
- Bankalar-Çeşitli (308)
- Bankalar-Bölgesel (2297)
- İpotek Finansı (171)
- Sermaye Piyasaları (888)
- Finansal Veriler ve Borsalar (151)
- Sigorta-Hayat (260)
- Sigorta-Mülk ve Hasar (270)
- Sigorta-Reasürans (74)
- Sigorta-Özel (72)
- Sigorta Komisyoncuları (67)
- Sigorta-Çeşitli (306)
- Paravan Şirketler (1820)
- Finansal Holdingler (100)
- Kredi Hizmetleri (660)
- Gayrimenkul-Geliştirme (966)
- Gayrimenkul Hizmetleri (1145)
- Gayrimenkul-Çeşitli (316)
- REIT-Sağlık Hizmetleri Tesisleri (64)
- REIT-Otel ve Motel (86)
- REIT-Endüstriyel (141)
- REIT-Ofis (169)
- REIT-Konut (108)
- REIT-Perakende (230)
- REIT-İpotek (130)
- REIT-Özel (83)
- REIT-Çeşitli (332)
- İçecekler-Bira Üreticileri (162)
- İçecekler-Şarap ve İçki İmalathaneleri (242)
- İçecekler-Alkolsüz (217)
- Şekerlemeciler (170)
- Çiftlik Ürünleri (610)
- Ev Eşyaları ve Kişisel Ürünler (523)
- Ambalajlı Gıdalar (1270)
- Eğitim ve Öğretim Hizmetleri (305)
- İndirim Mağazaları (97)
- Yemek Dağıtım (210)
- Marketler (233)
- Tütün (105)
- Biyoteknoloji (2611)
- İlaç Üreticileri-Genel (279)
- İlaç Üreticileri-Özel ve Genel (1705)
- Sağlık Hizmeti Planları (57)
- Tıbbi Bakım Tesisleri (553)
- Farmasötik Perakendeciler (155)
- Sağlık Bilgileri Hizmetleri (419)
- Tıbbi Cihazlar (913)
- Tıbbi Ekipmanlar ve Malzemeler (501)
- Teşhis ve Araştırma (427)
- Medikal Ürün Dağıtımı (138)
- Kamu Hizmetleri-Bağımsız Güç Üreticileri (170)
- Kamu Hizmetleri-Yenilenebilir (561)
- Kamu Hizmetleri-Su Tedariki (173)
- Kamu Hizmetleri-Elektrik Tedariki (468)
- Kamu Hizmetleri-Doğalgaz Tedariki (205)
- Kamu Hizmetleri-Çeşitli (214)
- Telekomünikasyon Hizmetleri (910)
- Reklam Ajansları (508)
- Yayımcılık (259)
- Yayıncılık (213)
- Eğlence (679)
- İnternet İçerikleri ve Bilgiler (530)
- Elektronik Oyunlar ve Multimedya (484)
- Petrol ve Gaz Sondajlama (80)
- Petrol ve Gaz Arama ve Üretimi (1185)
- Petrol ve Gaz - Entegre (246)
- Petrol ve Gaz - Orta Akım (230)
- Petrol ve Gaz Rafinesi ve Pazarlaması (278)
- Petrol ve Gaz Ekipmanları ve Hizmetleri (480)
- Termal Kömür (229)
- Uranyum (140)
- Hava-uzay ve Savunma (560)
- Özel İş Hizmetleri (640)
- Danışmanlık Hizmetleri (195)
- Kiralama ve Leasing Hizmetleri (219)
- Güvenlik ve Koruma Hizmetleri (267)
- İstihdam ve İşe Alım Hizmetleri (252)
- Holdingler (723)
- Mühendislik ve İnşaat (1492)
- Altyapı Operasyonları (156)
- Yapı Ürünleri ve Ekipmanları (513)
- Tarım ve Ağır İş Makineleri (376)
- Endüstriyel Dağıtım (235)
- İş Ekipmanları ve Malzemeleri (142)
- Özel Endüstriyel Makineler (1720)
- Metal Üretimi (393)
- Kirlilik ve Arıtma Kontrolleri (265)
- Araçlar ve Aksesuarlar (240)
- Elektrikli Ekipmanlar ve Parçalar (897)
- Havalimanları ve Hava Hizmetleri (135)
- Hava Yolları (229)
- Demir Yolları (260)
- Deniz Taşımacılığı (505)
- Kamyon Taşımacılığı (99)
- Entegre Nakliye ve Lojistik (388)
- Atık Yönetimi (354)
- Bilişim Teknolojileri Hizmetleri (1178)
- Yazılım-Uygulama (2113)
- Uygulama-Altyapı (955)
- İletişim Ekipmanları (731)
- Bilgisayar Donanımı (434)
- Tüketici Elektroniği (282)
- Elektronik Bileşenler (971)
- Elektronik Ürün ve Bilgisayar Dağıtımı (239)
- Bilimsel ve Teknik Gereçler (347)
- Yarı İletken Ekipman ve Malzemeler (350)
- Yarı İletkenler (611)
- Güneş Enerjisi (222)
| Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK |
|---|
| Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Eli Lilly and Company LLY.DE | $629.1 687.69 USD |
-8.08
|
$564.92B 617.54B USD | $5.75K 6.28K USD | $625.1 683.32 USD | $659.7 721.14 USD | $564.92B 617.54B USD | 58.52 | $10.75 11.75 USD | |
| Johnson & Johnson JNJ.BA | $13,850 16.37 USD |
+1.47
|
$394.37T 466.16B USD | $10.55K 12.47 USD | $13,300 15.72 USD | $14,500 17.14 USD | $394.37T 466.16B USD | 11.12 | $1.24K 1.47 USD | |
| Johnson & Johnson JNJ.MX | $3,067 181.6 USD |
-2.63
|
$7.39T 437.64B USD | $150 8.88 USD | $3,015 178.52 USD | $3,067 181.6 USD | $7.39T 437.64B USD | 25.55 | $120.01 7.11 USD | |
| Johnson & Johnson JNJB34.SA | $58.25 11.81 USD |
-1.52
|
$2.11T 426.89B USD | $5.62K 1.14K USD | $57.4 11.63 USD | $60.05 12.17 USD | $2.11T 426.89B USD | 25.54 | $2.28 0.46 USD | |
| AbbVie Inc. ABBV.BA | $24,125 28.52 USD |
+1.05
|
$337.64T 399.1B USD | $910 1.08 USD | $22,550 26.65 USD | $25,500 30.14 USD | $337.64T 399.1B USD | 9.39 | $2.57K 3.04 USD | |
| Johnson & Johnson JNJ.SN | $148.27 — |
0
|
$396.76B — | $0 — | $145.55 — | $145.55 — | $396.76B — | 22.43 | $6.61 — | |
| AbbVie Inc. ABBV.MX | $3,670 217.31 USD |
0
|
$6.49T 384.42B USD | $2 0.12 USD | $3,670 217.31 USD | $3,670 217.31 USD | $6.49T 384.42B USD | 74.06 | $49.55 2.93 USD | |
| AbbVie Inc. ABBV34.SA | $66.02 13.38 USD |
+2.47
|
$1.88T 381.85B USD | $5.66K 1.15K USD | $60.17 12.2 USD | $66.02 13.38 USD | $1.88T 381.85B USD | 75.02 | $0.88 0.18 USD | |
| Johnson & Johnson JNJ.F | $137.44 150.24 USD |
+1.43
|
$335.94B 367.23B USD | $1.62K 1.77K USD | $129.5 141.56 USD | $139.18 152.14 USD | $335.94B 367.23B USD | 25.88 | $5.31 5.8 USD | |
| Johnson & Johnson JNJ.VI | $132.44 144.77 USD |
-4.6
|
$319.16B 348.89B USD | $1.2K 1.31K USD | $128.32 140.27 USD | $135.48 148.1 USD | $319.16B 348.89B USD | 25.08 | $5.28 5.77 USD | |
| AbbVie Inc. 4AB.F | $160.8 175.78 USD |
-6.62
|
$284.45B 310.94B USD | $315 344.34 USD | $148.4 162.22 USD | $160.8 175.78 USD | $284.45B 310.94B USD | 73.42 | $2.19 2.39 USD | |
| AbbVie Inc. 4AB.DE | $152 166.16 USD |
-9.95
|
$268.88B 293.93B USD | $1.65K 1.81K USD | $148.8 162.66 USD | $158.8 173.59 USD | $268.88B 293.93B USD | 69.40 | $2.19 2.39 USD | |
| AbbVie Inc. ABBV.VI | $151.8 165.94 USD |
-11.64
|
$268.53B 293.54B USD | $0 0 USD | $151.8 165.94 USD | $158 172.72 USD | $268.53B 293.54B USD | 69.63 | $2.18 2.38 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| Roche Holding AG ROGN.MX | $5,859.95 346.98 USD |
-5.71
|
$4.55T 269.48B USD | $67 3.97 USD | $5,859.95 346.98 USD | $5,859.95 346.98 USD | $4.55T 269.48B USD | 23.63 | $247.98 14.68 USD | |
| Merck & Co., Inc. MRK.BA | $22,275 26.33 USD |
+4.33
|
$223.73T 264.45B USD | $6.17K 7.29 USD | $20,975 24.79 USD | $22,300 26.36 USD | $223.73T 264.45B USD | 0.30 | $72.47K 85.66 USD | |
| Novartis AG NVSN.MX | $2,235 132.34 USD |
0
|
$4.41T 261.38B USD | $0 0 USD | $2,235 132.34 USD | $2,235 132.34 USD | $4.41T 261.38B USD | 18.38 | $121.58 7.2 USD | |
| AstraZeneca PLC AZN.BA | $44,575 52.69 USD |
+0.17
|
$220.55T 260.69B USD | $4.42K 5.22 USD | $42,350 50.06 USD | $45,075 53.28 USD | $220.55T 260.69B USD | 9.21 | $4.84K 5.72 USD | |
| Novartis AG NVS.BA | $34,800 41.13 USD |
-1.49
|
$215.67T 254.93B USD | $91 0.11 USD | $33,800 39.95 USD | $34,900 41.25 USD | $215.67T 254.93B USD | 2.75 | $12.62K 14.92 USD | |
| AstraZeneca PLC A1ZN34.SA | $65.49 13.27 USD |
+1.72
|
$1.23T 249.79B USD | $3.16K 641.29 USD | $62.16 12.6 USD | $65.49 13.27 USD | $1.23T 249.79B USD | 29.49 | $2.22 0.45 USD | |
| Merck & Co., Inc. MRCK34.SA | $59.97 12.15 USD |
+3.45
|
$1.22T 247.41B USD | $5.32K 1.08K USD | $57.85 11.73 USD | $59.97 12.15 USD | $1.22T 247.41B USD | 12.01 | $4.99 1.01 USD | |
| Merck & Co., Inc. MRK.MX | $1,640 97.11 USD |
+0.43
|
$4.15T 245.54B USD | $182 10.78 USD | $1,610 95.33 USD | $1,644 97.34 USD | $4.15T 245.54B USD | 11.74 | $139.61 8.27 USD | |
| Merck & Co., Inc. MRK.SN | $96.42 — |
-25.14
|
$243.56B — | $0 — | $96.42 — | $96.42 — | $243.56B — | 14.30 | $6.74 — | |
| AstraZeneca PLC AZNN.MX | $1,317 77.98 USD |
-3.16
|
$4.11T 243.09B USD | $616 36.47 USD | $1,294 76.62 USD | $1,317 77.98 USD | $4.11T 243.09B USD | 28.23 | $46.65 2.76 USD | |
| Novartis AG N1VS34.SA | $60.42 12.25 USD |
-2.69
|
$1.19T 241.87B USD | $127 25.74 USD | $59.42 12.04 USD | $60.42 12.25 USD | $1.19T 241.87B USD | 17.41 | $3.47 0.7 USD | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| Roche Holding AG RHHVF | $277 — |
-3.48
|
$225.02B — | $199 — | $277 — | $281 — | $225.02B — | 22.87 | $12.11 — | |
| Roche Holding AG RHHBF | $296 — |
-8.92
|
$225B — | $6 — | $296 — | $296 — | $225B — | 24.42 | $12.12 — | |
| Roche Holding AG RHO6.F | $31.9 34.87 USD |
-4.49
|
$204.02B 223.02B USD | $469 512.68 USD | $31.8 34.76 USD | $31.9 34.87 USD | $204.02B 223.02B USD | 23.28 | $1.37 1.5 USD | |
| Amgen Inc. AMGN.MX | $6,430 380.73 USD |
0
|
$3.45T 204.53B USD | $0 0 USD | $6,430 380.73 USD | $6,430 380.73 USD | $3.45T 204.53B USD | 41.15 | $156.25 9.25 USD | |
| AstraZeneca PLC AZNCF | $131.19 — |
-0.31
|
$203.37B — | $317 — | $124 — | $131.19 — | $203.37B — | 29.15 | $4.5 — | |
| Merck & Co., Inc. 6MK.F | $72.6 79.36 USD |
+0.83
|
$184.25B 201.41B USD | $694 758.64 USD | $67.9 74.22 USD | $72.6 79.36 USD | $184.25B 201.41B USD | 11.74 | $6.18 6.76 USD | |
| AstraZeneca PLC ZEGA.F | $57.5 62.86 USD |
-4.96
|
$178.27B 194.87B USD | $65 71.05 USD | $57.5 62.86 USD | $58 63.4 USD | $178.27B 194.87B USD | 27.91 | $2.06 2.25 USD | |
| Amgen Inc. AMGN.BA | $12,950 15.31 USD |
+1.57
|
$164.42T 194.36B USD | $1.2K 1.42 USD | $12,350 14.6 USD | $13,125 15.51 USD | $164.42T 194.36B USD | 0.31 | $40.64K 48.04 USD | |
| Merck & Co., Inc. MRK.VI | $69.7 76.19 USD |
-5.68
|
$176.06B 192.46B USD | $1.64K 1.79K USD | $68.5 74.88 USD | $71.3 77.94 USD | $176.06B 192.46B USD | 11.37 | $6.13 6.7 USD | |
| Novartis AG NOTA.F | $89 97.29 USD |
-7.68
|
$175.78B 192.15B USD | $502 548.75 USD | $88.2 96.41 USD | $92 100.57 USD | $175.78B 192.15B USD | 16.54 | $5.38 5.88 USD | |
| AstraZeneca PLC ZEG.F | $113.25 123.8 USD |
-7.48
|
$175.56B 191.91B USD | $84 91.82 USD | $113.25 123.8 USD | $115.85 126.64 USD | $175.56B 191.91B USD | 27.48 | $4.12 4.5 USD | |
| Amgen Inc. AMGN34.SA | $60.27 12.22 USD |
+0.27
|
$906.56B 183.75B USD | $391 79.25 USD | $57.6 11.67 USD | $60.27 12.22 USD | $906.56B 183.75B USD | 37.66 | $1.6 0.32 USD | |
| Gilead Sciences, Inc. GILD.BA | $35,675 42.17 USD |
+1.71
|
$140.69T 166.3B USD | $1.35K 1.59 USD | $34,725 41.05 USD | $36,650 43.32 USD | $140.69T 166.3B USD | 87.68 | $406.87 0.48 USD | |
| Pfizer Inc. PFE.BA | $7,760 9.17 USD |
+3.88
|
$138.36T 163.54B USD | $27.92K 33.01 USD | $7,240 8.56 USD | $7,810 9.23 USD | $138.36T 163.54B USD | 2.55 | $3.03K 3.58 USD | |
| Gilead Sciences, Inc. GILD.MX | $2,191.09 129.74 USD |
0
|
$2.73T 161.74B USD | $2 0.12 USD | $2,191.09 129.74 USD | $2,191.09 129.74 USD | $2.73T 161.74B USD | 277.70 | $7.89 0.47 USD | |
| Gilead Sciences, Inc. GILD34.SA | $308.9 62.61 USD |
-3.17
|
$770.17B 156.1B USD | $80 16.21 USD | $308.9 62.61 USD | $310.5 62.93 USD | $770.17B 156.1B USD | 275.80 | $1.12 0.23 USD | |
| Amgen Inc. AMG.F | $262.6 287.06 USD |
+0.63
|
$141.07B 154.21B USD | $242 264.54 USD | $238 260.17 USD | $262.6 287.06 USD | $141.07B 154.21B USD | 37.94 | $6.92 7.56 USD | |
| Pfizer Inc. PFIZ34.SA | $32.97 6.68 USD |
+2.81
|
$753.42B 152.71B USD | $0 0 USD | $0 0 USD | $0 0 USD | $753.42B 152.71B USD | 15.85 | $2.08 0.42 USD | |
| Pfizer Inc. PFE.MX | $452 26.76 USD |
-0.6
|
$2.56T 151.79B USD | $5.83K 345.33 USD | $440 26.05 USD | $457 27.06 USD | $2.56T 151.79B USD | 15.48 | $29.19 1.73 USD | |
| Pfizer Inc. PFE.SN | $26.06 — |
0
|
$147.8B — | $0 — | $26.06 — | $26.06 — | $147.8B — | 18.48 | $1.41 — | |
| Amgen Inc. AMGN.VI | $248.05 271.15 USD |
-6.99
|
$133.25B 145.66B USD | $737 805.64 USD | $241.05 263.5 USD | $251.55 274.98 USD | $133.25B 145.66B USD | 36.05 | $6.88 7.52 USD | |
| Amgen Inc. AMG.DE | $247.8 270.88 USD |
-7.38
|
$133.12B 145.52B USD | $934 1.02K USD | $240.85 263.28 USD | $250.7 274.05 USD | $133.12B 145.52B USD | 35.75 | $6.93 7.58 USD | |
| Gilead Sciences, Inc. GILD.SN | $95.78 — |
+6.77
|
$137.34B — | $0 — | $95.78 — | $95.78 — | $137.34B — | 252.05 | $0.38 — | |
| Bristol-Myers Squibb Company BMY.BA | $24,025 28.4 USD |
-0.93
|
$115.03T 135.97B USD | $1.64K 1.94 USD | $22,950 27.13 USD | $24,075 28.46 USD | $115.03T 135.97B USD | 0 | -$4,740 -5.6 USD | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $305.54 61.93 USD |
+2.18
|
$652.86B 132.32B USD | $215 43.58 USD | $305.54 61.93 USD | $308.44 62.52 USD | $652.86B 132.32B USD | 0 | -$26.1 -5.2 USD | |
| Bristol-Myers Squibb Company BMY.MX | $1,086.12 64.31 USD |
-4.16
|
$2.21T 130.86B USD | $371 21.97 USD | $1,054.65 62.45 USD | $1,086.12 64.31 USD | $2.21T 130.86B USD | 0 | -$91.34 -5.4 USD | |
| Gilead Sciences, Inc. GIS.F | $94 102.75 USD |
-0.13
|
$117.72B 128.68B USD | $1.38K 1.51K USD | $89.44 97.77 USD | $94 102.75 USD | $117.72B 128.68B USD | 268.57 | $0.35 0.38 USD | |
| Gilead Sciences, Inc. GILD.VI | $92.35 100.95 USD |
-5.18
|
$115.13B 125.85B USD | $1.23K 1.35K USD | $88.23 96.45 USD | $93.23 101.91 USD | $115.13B 125.85B USD | 263.85 | $0.35 0.38 USD | |
| Gilead Sciences, Inc. GIS.DE | $92.3 100.9 USD |
-5.39
|
$115.06B 125.78B USD | $9.08K 9.93K USD | $88.45 96.69 USD | $94.42 103.21 USD | $115.06B 125.78B USD | 263.71 | $0.35 0.38 USD | |
| Sanofi SNYNF | $100.55 — |
0
|
$122.79B — | $200 — | $99 — | $99 — | $122.79B — | 20.81 | $4.83 — | |
| Pfizer Inc. PFE.VI | $19.24 21.04 USD |
-5.57
|
$109.14B 119.31B USD | $10.38K 11.35K USD | $18.8 20.55 USD | $19.75 21.59 USD | $109.14B 119.31B USD | 15.03 | $1.28 1.4 USD | |
| Sanofi SNW2.F | $44.4 48.54 USD |
-4.31
|
$108.44B 118.54B USD | $100 109.31 USD | $44.4 48.54 USD | $44.4 48.54 USD | $108.44B 118.54B USD | 20.27 | $2.19 2.39 USD | |
| Pfizer Inc. PFEB.F | $6.05 6.61 USD |
-6.2
|
$106.45B 116.37B USD | $209 228.47 USD | $6.05 6.61 USD | $6.05 6.61 USD | $106.45B 116.37B USD | 13.75 | $0.44 0.48 USD | |
| Sanofi SNW.F | $87.05 95.16 USD |
-5.38
|
$106.3B 116.2B USD | $884 966.33 USD | $86.62 94.69 USD | $90.8 99.26 USD | $106.3B 116.2B USD | 19.82 | $4.39 4.8 USD | |
| Sanofi SANO.VI | $87.03 95.14 USD |
-6.79
|
$106.28B 116.18B USD | $0 0 USD | $86.95 95.05 USD | $88.25 96.47 USD | $106.28B 116.18B USD | 19.82 | $4.39 4.8 USD | |
| GSK plc GSK.BA | $12,000 14.18 USD |
+3.23
|
$97.42T 115.15B USD | $942 1.11 USD | $11,125 13.15 USD | $12,000 14.18 USD | $97.42T 115.15B USD | 28.20 | $425.48 0.5 USD | |
| Bristol-Myers Squibb Company BRM.F | $47.8 52.25 USD |
-2.2
|
$97.26B 106.32B USD | $125 136.64 USD | $45.72 49.98 USD | $47.86 52.31 USD | $97.26B 106.32B USD | 0 | -$4.04 -4.4 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $45.56 49.8 USD |
-9.56
|
$92.69B 101.33B USD | $0 0 USD | $45.56 49.8 USD | $47.68 52.12 USD | $92.69B 101.33B USD | 0 | -$4.01 -4.3 USD | |
| Bristol-Myers Squibb Company BRM.DE | $45.52 49.75 USD |
-8.74
|
$92.61B 101.24B USD | $1.6K 1.74K USD | $45.25 49.46 USD | $48 52.47 USD | $92.61B 101.24B USD | 0 | -$4.04 -4.4 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| GSK plc GSKN.MX | $811 48.02 USD |
0
|
$1.65T 97.46B USD | $0 0 USD | $811 48.02 USD | $811 48.02 USD | $1.65T 97.46B USD | 24.75 | $32.76 1.94 USD | |
| GSK plc G1SK34.SA | $41.97 8.51 USD |
+1.01
|
$425.91B 86.32B USD | $14 2.84 USD | $41.97 8.51 USD | $41.97 8.51 USD | $425.91B 86.32B USD | 22.44 | $1.87 0.38 USD | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $39.12 42.76 USD |
-4.16
|
$64.37B 70.37B USD | $30 32.79 USD | $39.12 42.76 USD | $39.75 43.45 USD | $64.37B 70.37B USD | 26.79 | $1.46 1.6 USD | |
| GSK GLAXF | $17 — |
0
|
$69.79B — | $497 — | $17 — | $17 — | $69.79B — | 21.25 | $0.8 — | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $19.7 21.53 USD |
-6.5
|
$36.82B 40.25B USD | $22 24.05 USD | $19.53 21.34 USD | $19.7 21.53 USD | $36.82B 40.25B USD | 24.62 | $0.8 0.87 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $46.6 50.94 USD |
+4.95
|
$25.47B 27.84B USD | $19 20.77 USD | $43 47 USD | $46.6 50.94 USD | $25.47B 27.84B USD | 11.85 | $3.93 4.3 USD | |
| Biogen Inc. BIIB.MX | $2,854 168.99 USD |
0
|
$417.75B 24.74B USD | $0 0 USD | $2,854 168.99 USD | $2,854 168.99 USD | $417.75B 24.74B USD | 12.33 | $231.46 13.71 USD | |
| Biogen Inc. BIIB.BA | $12,575 14.86 USD |
+4.57
|
$18.77T 22.19B USD | $421 0.5 USD | $11,675 13.8 USD | $12,575 14.86 USD | $18.77T 22.19B USD | 1.04 | $12.02K 14.21 USD | |
| Bayer Aktiengesellschaft BAYA.F | $4.8 5.25 USD |
+0.42
|
$20.13B 22.01B USD | $1K 1.09K USD | $4.72 5.16 USD | $4.84 5.29 USD | $20.13B 22.01B USD | 0 | -$0.65 -0.7 USD | |
| Bayer Aktiengesellschaft BAYER.BD | $8,079 22.34 USD |
-4.05
|
$7.94T 21.95B USD | $197 0.54 USD | $8,071 22.32 USD | $8,180 22.62 USD | $7.94T 21.95B USD | 0 | -$1,058.3 -2.9 USD | |
| Biogen Inc. BIIB34.SA | $116.93 23.7 USD |
-0.16
|
$103.11B 20.9B USD | $1 0.2 USD | $116.93 23.7 USD | $116.93 23.7 USD | $103.11B 20.9B USD | 10.63 | $10.99 2.23 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $19.39 21.2 USD |
-6.4
|
$19.05B 20.82B USD | $2.65K 2.89K USD | $19.39 21.19 USD | $20 21.86 USD | $19.05B 20.82B USD | 0 | -$2.6 -2.8 USD | |
| Astellas Pharma Inc. YPH.F | $8.22 8.98 USD |
+4.98
|
$15.62B 17.07B USD | $27 29.51 USD | $7.71 8.43 USD | $8.22 8.98 USD | $15.62B 17.07B USD | 0 | -$0.2 -0.2 USD | |
| Biogen Inc. BIIB.VI | $101.8 111.28 USD |
-5.87
|
$14.9B 16.29B USD | $615 672.28 USD | $98.96 108.18 USD | $102.8 112.37 USD | $14.9B 16.29B USD | 10.00 | $10.18 11.13 USD | |
| Biogen Inc. IDP.DE | $101.7 111.17 USD |
-6.14
|
$14.89B 16.27B USD | $934 1.02K USD | $99 108.22 USD | $103.15 112.76 USD | $14.89B 16.27B USD | 9.93 | $10.24 11.19 USD | |
| Biogen Inc. IDP.F | $100.2 109.53 USD |
-2.77
|
$14.87B 16.26B USD | $100 109.31 USD | $100.2 109.53 USD | $103.15 112.76 USD | $14.87B 16.26B USD | 9.78 | $10.24 11.19 USD | |
| Astellas Pharma ALPMF | $9 — |
0
|
$16.24B — | $200 — | $8.96 — | $9 — | $16.24B — | 0 | -$0.22 — | |
| Astellas Pharma Inc. YPHA.F | $7.55 8.25 USD |
-4.43
|
$14.22B 15.54B USD | $0 0 USD | $7.55 8.25 USD | $7.55 8.25 USD | $14.22B 15.54B USD | 0 | -$0.2 -0.2 USD | |
| Cipla Limited CIPLA.BO | $1,416.3 17.13 USD |
-1.2
|
$1.14T 13.84B USD | $53.37K 645.69 USD | $1,395.5 16.88 USD | $1,422.15 17.21 USD | $1.14T 13.84B USD | 22.92 | $61.78 0.75 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $44.12 48.23 USD |
-7.12
|
$9.09B 9.93B USD | $5 5.47 USD | $44.12 48.23 USD | $45.76 50.02 USD | $9.09B 9.93B USD | 22.17 | $1.99 2.18 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $44.06 48.16 USD |
-7.32
|
$9.08B 9.92B USD | $0 0 USD | $44.06 48.16 USD | $46.24 50.55 USD | $9.08B 9.92B USD | 22.14 | $1.99 2.18 USD | |
| Orion Oyj OFK.F | $51 55.75 USD |
+5.07
|
$7.47B 8.16B USD | $66 72.15 USD | $48.98 53.54 USD | $51 55.75 USD | $7.47B 8.16B USD | 21.70 | $2.35 2.57 USD | |
| Kyowa Kirin KYKOF | $14.75 — |
0
|
$7.72B — | $316 — | $14.75 — | $14.75 — | $7.72B — | 18.91 | $0.78 — | |
| Orion Oyj ORINF | $48.65 — |
0
|
$7.63B — | $43 — | $47.16 — | $47.16 — | $7.63B — | 19.69 | $2.47 — | |
| Abbott India Limited ABBOTINDIA.BO | $29,136.1 352.5 USD |
-0.94
|
$619.12B 7.49B USD | $182 2.2 USD | $28,980.9 350.62 USD | $29,599.9 358.11 USD | $619.12B 7.49B USD | 46.28 | $629.45 7.62 USD | |
| Abbott India Limited ABBOTINDIA.NS | $29,108.05 352.16 USD |
-0.99
|
$618.83B 7.49B USD | $5.19K 62.84 USD | $28,975.55 350.56 USD | $29,600.05 358.11 USD | $618.83B 7.49B USD | 46.26 | $629.14 7.61 USD | |
| Orion Oyj OFK0.F | $24.2 26.45 USD |
-3.97
|
$6.82B 7.46B USD | $0 0 USD | $24.2 26.45 USD | $24.2 26.45 USD | $6.82B 7.46B USD | 20.68 | $1.17 1.28 USD | |
| Kyowa Kirin Co., Ltd. KY4.F | $12.7 13.88 USD |
-2.31
|
$6.65B 7.27B USD | $254 277.66 USD | $12.7 13.88 USD | $12.8 13.99 USD | $6.65B 7.27B USD | 18.14 | $0.7 0.77 USD | |
| CSPC Pharmaceutical Group Limited CVGU.F | $2.08 2.27 USD |
0
|
$6.59B 7.21B USD | $250 273.28 USD | $2.08 2.27 USD | $2.08 2.27 USD | $6.59B 7.21B USD | 11.55 | $0.18 0.2 USD | |
| CSPC Pharmaceutical CHJTF | $0.6199 — |
+0.1
|
$7.19B — | $20K — | $0.6199 — | $0.6199 — | $7.19B — | 12.40 | $0.05 — | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.56 0.61 USD |
-0.22
|
$6.58B 7.19B USD | $1K 1.09K USD | $0.56 0.61 USD | $0.56 0.61 USD | $6.58B 7.19B USD | 11.11 | $0.05 0.05 USD | |
| Orion Oyj ORINY | $26.31 — |
-15.29
|
$7.19B — | $101 — | $26.31 — | $26.31 — | $7.19B — | 20.39 | $1.29 — | |
|
Favori hisse senedi yok.
Henüz favori bir hisse senediniz yok, lütfen burada görmek için favorilere ekleyin |
||||||||||
- {{ link.label }} {{link}}